ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v16i5.2058ppharm-1771Research ArticleРЕДАКЦИОННЫЕ СТАТЬИAN EDITORIAL ARTICLEЕвропейский стратегический форум по аллергическим болезням: определение приоритетов научных проблем и финансирования в отношении аллергии и бронхиальной астмы и необходимость трансляционных исследованийPrioritizing Research Challenges and Funding for Allergy and Asthma and the Need for Translational Research — The European Strategic Forum on Allergic Diseaseshttps://orcid.org/0000-0001-7994-364XАгачеИоанаAgacheI.

Брашов

Brasov

Аннеси-МаэсаноИзабеллаAnnesi-MaesanoI.

Париж

Department of Epidemiology of Allergic and Respiratory Diseases

Paris

https://orcid.org/0000-0002-6846-9265БонертцАндреасBonertzA.

Ланген

Langen

БранкаФранческоBrancaF.

Женева

Geneva

КантЭндрюCantA.ФрасЗлаткоFrasZ.

Любляны

Division of Medicine, University Medical Centre Ljubljana;

Medical Faculty, University of Ljubljana

Ljubljana

ИнгенриетФранкIngenriethF.

Брюссель

Bruxelles

https://orcid.org/0000-0002-2209-7531Намазова-БарановаЛейлаNamazova-BaranovaL.

Намазова-Баранова Лейла Сеймуровна, д.м.н, профессор, академик РАН, заведующая кафедрой факультетской педиатрии педиатрического факультета РНИМУ им. Н.И. Пирогова, руководитель НИИ педиатрии и охраны здоровья детей ЦКБ РАН

119333, Москва, ул. Фотиевой, д. 10, тел.: +7 (495) 104-85-97

Department of Pediatrics

Moscow

leyla.s.namazova@gmail.comОдемирМикаэлаOdemyrM.

Брюссель

Brussels

СпаневеллоАнтониоSpanevelloA.

Кафедра медицины, хирургии, болезней органов дыхания, Университет Инсубрия, Комо и Варезе;

Департамент медицины и реабилитации кардиореспираторной деятельности, Научно-исследовательский институт Маугери, IRCCS Традате

Традате

Dipartimento di Medicina e Chirurgia, Malattie dell’Apparato Respiratorio, Università degli Studi dell’Insubria, Varese – Como;

Dipartimento di Medicina e Riabilitazione Cardio Respiratoria, U.O. di Pneumologia Riabilitativa, Istituti Clinici Scientifici Maugeri, IRCCS Tradate, Tradate

ВиетсСтефанViethsS.

Ланген

Langen

ЙоргансиоглуАрзуYorganciogluA.

Кафедра пульмонологии, Медицинский факультет 

Маниса

Department of Pulmonology

Manisa

Альваро-ЛосаноМонтсератAlvaro-LozanoM.

Детское отделение аллергологии и клинической иммунологии

Pediatric Allergy and Clinical Immunology Department

Barcelona

Барбер ЭрнандесДомингоBarber HernandezD.

Кафедра фундаментальных медицинских наук, Медицинский факультет, Университет Святого Павла

Мадрид

Department of Basic Medical Sciences, School of Medicine, Universidad CEU San Pablo

Madrid

ЧиватоТомасChivatoT.

Медицинский факультет

Мадрид

School of Medicine

Madrid

Дель ДжаккоСтефаноDel GiaccoS.

Кафедра медицинских наук и общественного здравоохранения

Кальяри

Department of Medical Sciences and Public Health

Cagliari

ДиамантЗузаннаDiamantZ.

Отделение пульмонологии и аллергологии, Институт клинических наук, Университетская клиника Скане, Университет Лунда, Лунд, Швеция;

Кафедра пульмонологии, Первый медицинский факультет, Карлов университет и больница Томайера, Прага, Чешская Республика

Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden;

Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic

Эгилуз-ГрасиаИбонEguiluz-GraciaI.

Аллергологическое отделение

Allergy Unit, IBIMA, Regional University Hospital of Malaga, UMA

Malaga

ван ВейкРой ГертVan WijkR. G.

Отдел аллергологии, терапевтическое отделение

Роттердам

Section of Allergology, Department of Internal Medicine

Rotterdam

ГевартФилиппGevaertP.

Кафедра оториноларингологии с хирургической группой заболеваний головы и шеи

Гент

Department of Otorhinolaryngology‐Head and Neck Surgery, Upper Airways Research Laboratory

Ghent

ГрасельАнкеGraesselA.ХеллингсПитерHellingsP.

Кафедра оториноларингологии с хирургической группой заболеваний головы и шеи, Исследовательская лаборатория Гентского университета, Гент;

Оториноларингологическое отделение с хирургической группой заболеваний головы и шеи, Университетская клиника в Левене, Левен;

Оториноларингологическое отделение, Медицинский центр Амстердама, Амстердам, Нидерланды

Department of Otorhinolaryngology‐Head and Neck Surgery, Upper Airways Research Laboratory, Ghent University, Ghent, Belgium;

Department of Otorhinolaryngology‐Head and Neck Surgery, UZ Leuven, Leuven, Belgium;

Department of Otorhinolaryngology, Academic Medical Center, Amsterdam, The Netherlands

Хоффманн-ЗоммергруберКаринHoffmann-SommergruberK.

Кафедра патофизиологии и исследований аллергии

Вена

Department of Pathophysiology and Allergy Research

Vienna 

ДжутелМарекJutelM.

Кафедра клинической иммунологии 

Вроцлав

Department of Clinical Immunology, Wroclaw Medical University

Wroclaw

ЛауСюзаннаLauS.

Отделение детской пульмонологии, иммунологии и интенсивной терапии

Берлин

Department for Pediatric Pneumology, Immunology and Intensive Care

Berlin

ЛауэрмаАнттиLauermaA.

Отделение дерматологии и аллергологии, университетская клиника

Хельсинки

Helsinki

Мария ОлагейбельХосеMaria OlaguibelJ.

Отделение тяжелой астмы

Памплона

Severe Asthma Unit

Pamplona

https://orcid.org/0000-0003-4705-3583О’МахониЛиамO’MahonyL.

Кафедра медицины и микробиологии, Институт микробиома APC

Корк

Departments of Medicine and Microbiology, APC Microbiome Ireland

Cork

ОздемирДжевдетOzdemirC.

Кафедра фундаментальных наук в педиатрии, Институт здоровья детей;

Кафедра педиатрии, отдел детской аллергологии и иммунологии, медицинский факультет

Стамбул

Department of Pediatric Basic Sciences, Institute of Child Health;

Department of Pediatrics, Division of Pediatric Allergy & Immunology, Istanbul Faculty of Medicine

Istanbul

ПаломаресОскарPalomaresO.

Кафедра биохимии и молекулярной биологии, Химический факультет

Мадрид

Department of Biochemistry and Molecular Biology, School of Chemistry

Madrid

https://orcid.org/0000-0003-4374-9639ПфаарОливерPfaarO.

Оториноларингологическое отделение с хирургической группой заболеваний головы и шеи, отделение ринологии и аллергии, Университетская больница Марбурга

Марбург

Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy

Marburg

https://orcid.org/0000-0003-4689-6837СастреХоакинSastreJ.

Аллергологическое отделение, Университетская больница им. Хименеса Диаса;

Медицинский факультет, Институт здоровья Карлоса III, CIBERES, Мадридский автономный университет

Мадрид

Department of Allergy, Fundación Jimenez Diaz;

Department of Medicine, Instituto Carlos III, CIBERES, Universidad Autónoma de Madrid

Madrid

СкаддингГленнисScaddingG.

Лондон

London

Шмидт-ВеберКарстенSchmidt-WeberC.

Центр аллергии и окружающей среды (ZAUM)

Мюнхен

Zentrums Allergie & Umwelt (ZAUM)

München

Шмид-ГрендельмейерПитерSchmid-GrendelmeierP.

Отдел аллергологии, отделение дерматологии, Университетская клиника Цюриха

Цюрих

Allergy Unit, Department of Dermatology, University Hospital of Zurich

Zurich

https://orcid.org/0000-0003-3425-3463ШамжиМохаммедShamjiM.

Лондон

London

https://orcid.org/0000-0003-3629-4293СкайпалаИзабельSkypalaI.

Лондон

London

СпинолаМоникаSpinolaM.

Милан

Milan

СпрангерОттоSprangerO.

Вена

Vienna

ТорресМарияTorresM.

Аллергологическое отделение

ВередаАндреаVeredaA.

Лондон

London

БониниСерхиоBoniniS.

Рим

Rome

Университет ТрансильванииРумынияTransylvania UniversityRomaniaМедицинская школа Сент-Антуан, IPLESP, INSERM и Университет СорбонныФранцияMedical School Saint Antoine, IPLESP, INSERM and Sorbonne UniversitéFranceФедеральное агентство по вакцинам и биомедицинским лекарственным средствам, Институт имени Пауля ЭрлихаГерманияFederal Agency for Vaccines and Biomedicines, Paul‐Ehrlich‐InstitutGermanyДепартамент питания; Штаб-квартира ВОЗШвейцарияDepartment of Nutrition for Health and Development; WHO/HQSwitzerlandНьюкаслский университет, Ньюкасл-апон-Тайн, Великобритания; Европейское общество по изучению иммунодефицитов, Женева, ШвейцарияВеликобританияUniversity of Newcastle Upon Tyne, Newcastle upon Tyne, UK; European Society for Immunodeficiencies, Geneva, SwitzerlandUnited KingdomУниверситетский медицинский центр Любляны; Медицинский факультет университета Любляны; Европейский союз медицинских специалистов, Брюссель, БельгияСловенияUniversity Medical Centre Ljubljana; University of Ljubljana; UEMS — Union Europeenne des Medecins Specialistes/European Union of Medical Specialists, Brussels, BelgiumSloveniaSCOPEБельгияSCOPE EuropeBelgiumРоссийский национальный исследовательский медицинский университет им. Н.И. Пирогова; Отделение педиатрии, Центральная клиническая больница РАНРоссияRussian National Research Medical University of MoH RF; Central Clinical Hospital of MoSHE (Ministry of Science and High Education)Russian FederationЕвропейская федерация ассоциаций пациентов, страдающих аллергией и болезнями верхних дыхательных путейБельгияEuropean Federation of Allergy and Airways Diseases Patients’ Associations (EFA)BelgiumУниверситет Инсубрия, Комо и Варезе; Научно-исследовательский институт Маугери, IRCCS ТрадатеИталияUniversità degli Studi dell’Insubria; Istituti Clinici Scientifici Maugeri, IRCCS TradateItalyУниверситет имени Джелала БаяраТурцияCelal Bayar University School of MedicineTurkeyБольница Сан-Хуан-де-Дью, БарселонаИспанияHospital Sant Joan de DéuSpainУниверситет Святого Павла; Институт здоровья Карлоса IIIИспанияUniversidad CEU San Pablo; Instituto de Salud Carlos IIISpainУниверситет Святого ПавлаИспанияUniversity CEU San PabloSpainУниверситет КальяриИталияUniversity of CagliariItalyУниверситет Лунда, Швеция; Карлов университет и больница Томайера, Чешская РеспубликаШвецияLund University, Sweden; Charles University and Thomayer Hospital, Czech RepublicSwedenБиомедицинский научно-исследовательский институт Малаги IBIMA, Областная университетская клиника, Малага; Институт здоровья Карлоса III, МадридИспанияUMA, Malaga; Carlos III Health Institute, MadridSpainМедицинский центр университета ЭразмусНидерландыErasmus Medical CenterNetherlandsИсследовательская лаборатория Гентского университетаБельгияGhent UniversityBelgiumAllergy Therapeutics, Уортинг, Великобритания; Bencard Allergie, Мюнхен, ГерманияГерманияAllergy Therapeutics, Worthing, UK; Bencard Allergie GmbH, Munich, GermanyGermanyИсследовательская лаборатория Гентского университета, Бельгия; Университетская клиника в Левене, Бельгия; Медицинский центр Амстердама, НидерландыБельгияGhent University, Belgium; UZ Leuven, Belgium; Academic Medical Center, Amsterdam, The NetherlandsBelgiumВенский медицинский университетАвстрияMedical University of ViennaAustriaВроцлавский медицинский университет; Исследовательский Институт и Клиника All-MedПольшаWroclaw Medical University; “ALL‐MED” Medical Research InstitutePolandКлинический комплекс ШаритеГерманияCharité Universität MedizinGermanyХельсинкский университетФинляндияDermatology and Allergology, Helsinki University Hospital; University of HelsinkiFinlandМедицинский центр в НаварреИспанияComplejo Hospitalario de NavarraSpainИрландский национальный университетИрландияNational University of IrelandIrelandСтамбульский университетТурцияIstanbul UniversityTurkeyМадридский университет КомплутенсеИспанияComplutense University of MadridSpainМарбургский университет имени ФилиппаГерманияUniversity Hospital Marburg, Philipps‐Universität MarburgGermanyУниверситетская больница им. Хименеса Диаса; Институт здоровья Карлоса III, CIBERES, Мадридский автономный университетИспанияFundación Jimenez Diaz; Instituto Carlos III, CIBERES, Universidad Autónoma de MadridSpainКоролевская национальная оториноларингологическая больница (RNTNE)ВеликобританияRNTNE HospitalUnited KingdomТехнический университет ГельмгольцаГерманияTechnische Universität und Helmholtz ZentrumGermanyУниверситетская клиника Цюриха; Центр исследования аллергии Christine Khne, ДавосШвейцарияUniversity Hospital of Zurich; Christine‐Kühne Center for Allergy Research and Education CK‐CARE DavosSwitzerlandНациональный институт сердца и легких; Центр по исследованию аллергических механизмов развития бронхиальной астмыВеликобританияAllergy & Clinical Immunology, Inflammation, Repair and Development, Imperial College, National Heart and Lung Institute, Immunomodulation and Tolerance Group; Asthma UK Centre in Allergic Mechanisms of AsthmaUnited KingdomБольница Ройал Бромптон и больница Харефилд, Национальная служба здравоохранения; Имперский колледж ЛондонаВеликобританияRoyal Brompton & Harefield NHS Foundation Trust; Imperial CollegeUnited KingdomЕвропейский отдел по медицинским вопросам, СанофиИталияEuropean Medical Affairs, SanofiItalyПлатформа для пациентов с аллергическими болезнями и бронхиальной астмойАвстрияGlobal Allergy and Asthma Patient PlatformAustriaБиомедицинский научно-исследовательский институт Малаги IBIMA, Областная университетская клиника, Малага; Институт здоровья Карлоса III, МадридИспанияAllergy Unit, IBIMA, Regional University Hospital of Malaga, UMA, Malaga; Carlos III Health Institute, MadridSpainAimmune TherapeuticsВеликобританияAimmune TherapeuticsUnited KingdomИнститут трансляционной фармакологии, Итальянский национальный исследовательский советИталияInstitute of Translational Pharmacology, Italian National Research CouncilItaly201917012020165281295Copyright © Агаче И., Аннеси-Маэсано И., Бонертц А., Бранка Ф., Кант Э., Фрас З., Ингенриет Ф., Намазова-Баранова Л., Одемир М., Спаневелло А., Виетс С., Йоргансиоглу А., Альваро-Лосано М., Барбер Эрнандес Д., Чивато Т., Дель Джакко С., Диамант З., Эгилуз-Грасиа И., ван Вейк Р.Г., Геварт Ф., Грасель А., Хеллингс П., Хоффманн-Зоммергрубер К., Джутел М., Лау С., Лауэрма А., Мария Олагейбель Х., О’Махони Л., Оздемир Д., Паломарес О., Пфаар О., Састре Х., Скаддинг Г., Шмидт-Вебер К., Шмид-Грендельмейер П., Шамжи М., Скайпала И., Спинола М., Спрангер О., Торрес М., Вереда А., Бонини С., 20202020Агаче И., Аннеси-Маэсано И., Бонертц А., Бранка Ф., Кант Э., Фрас З., Ингенриет Ф., Намазова-Баранова Л., Одемир М., Спаневелло А., Виетс С., Йоргансиоглу А., Альваро-Лосано М., Барбер Эрнандес Д., Чивато Т., Дель Джакко С., Диамант З., Эгилуз-Грасиа И., ван Вейк Р.Г., Геварт Ф., Грасель А., Хеллингс П., Хоффманн-Зоммергрубер К., Джутел М., Лау С., Лауэрма А., Мария Олагейбель Х., О’Махони Л., Оздемир Д., Паломарес О., Пфаар О., Састре Х., Скаддинг Г., Шмидт-Вебер К., Шмид-Грендельмейер П., Шамжи М., Скайпала И., Спинола М., Спрангер О., Торрес М., Вереда А., Бонини С.Agache I., Annesi-Maesano I., Bonertz A., Branca F., Cant A., Fras Z., Ingenrieth F., Namazova-Baranova L., Odemyr M., Spanevello A., Vieths S., Yorgancioglu A., Alvaro-Lozano M., Barber Hernandez D., Chivato T., Del Giacco S., Diamant Z., Eguiluz-Gracia I., van Wijk R.G., Gevaert P., Graessel A., Hellings P., Hoffmann-Sommergruber K., Jutel M., Lau S., Lauerma A., Maria Olaguibel J., O’Mahony L., Ozdemir C., Palomares O., Pfaar O., Sastre J., Scadding G., Schmidt-Weber C., Schmid-Grendelmeier P., Shamji M., Skypala I., Spinola M., Spranger O., Torres M., Vereda A., Bonini S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/1771

Европейская академия аллергологии и клинической иммунологии (European Academy of Allergy and Clinical Immunology, EAACI) организовала первый Европейский стратегический форум по аллергическим болезням и астме. Основной целью этого форума было объединение всех заинтересованных сторон и принимающих решения лиц в сферах аллергологии, бронхиальной астмы и клинической иммунологии для обсуждения сложившихся проблем и возможных вариантов их решения на ближайшее десятилетие. Форум продолжил следовать целям, изложенным в белой книге EAACI, по интеграции опыта Академии в совместные действия с партнерами. Это сотрудничество является ключевым для использования принципов ведения пациентов с аллергией и астмой в контексте современной реальности. Стратегический форум по аллергическим болезням собрал всех, кто хочет и может что-то изменить: национальные и международные сообщества, организации пациентов, контролирующие органы и представителей бизнеса. Обсуждение таких тем, как разработка новых лекарственных средств и биоинженерия, big data и информационные технологии, аллергия и астма в контексте экологической медицины, показало, что объединение усилий представителей передовой науки и организаторов здравоохранения, а также всех заинтересованных сторон вокруг основных приоритетов необходимо для лучшего управления аллергией и астмой в эру персонализированной медицины и всеобщего доступа к инновациям и современным методам диагностики и лечения.

The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision‐makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy’s output with the perspective offered by EAACI’s partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real‐world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients’ organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.

аллергические болезнибронхиальная астмаbig-dataэкологическая медицинаэкспосомприкладная наукакритерии качестватрансляционное исследованиеallergic diseasesasthmabig dataenvironmental healthexposomeimplementation sciencequality criteriatranslational researchАвторы статьи выражают благодарность Киаре Хартман и Ане Антунес из руководства EAACI за оказанную помощь в организации Стратегического форума и в написании этой работы.The authors thank Chiara Hartman and Ana Antunes from the EAACI HQ for the support in organizing the Strategic Forum and in drafting this manuscript.ReferencesAgache I, Akdis CA, Chivato T, et al. EAACI white paper on research, innovation and quality care [Accessed 2019 Febr 14]. Available from: www.eaaci.org/resources/books/white-paper.html.Agache I, Akdis CA, Chivato T, et al. EAACI white paper on research, innovation and quality care [Accessed 2019 Febr 14]. Available from: www.eaaci.org/resources/books/white-paper.html.Bion V, Lockett GA, Soto-Ramírez N, et al. Evaluating the efficacy of breastfeeding guidelines on long-term outcomes for allergic disease. Allergy. 2016;71(5):661–670. doi: 10.1111/all.12833.Bion V, Lockett GA, Soto-Ramírez N, et al. Evaluating the efficacy of breastfeeding guidelines on long-term outcomes for allergic disease. Allergy. 2016;71(5):661–670. doi: 10.1111/all.12833.Victora CG, Bahl R, Barros A, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387:475–490. doi: 10.1016/S0140-6736(15)01024-7.Victora CG, Bahl R, Barros A, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387:475–490. doi: 10.1016/S0140-6736(15)01024-7.Nwaru BI, Hickstein L, Panesar SS, et al. Prevalence of common food allergies in Europe: a systematic review and meta-analysis. Allergy. 2014;69(8):992–1007. doi: 10.1111/all.12423.Nwaru BI, Hickstein L, Panesar SS, et al. Prevalence of common food allergies in Europe: a systematic review and meta-analysis. Allergy. 2014;69(8):992–1007. doi: 10.1111/all.12423.Muraro A, Agache I, Clark A, et al.; European Academy of Allergy and Clinical Immunology. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community. Allergy. 2014;69(8):1046–1057. doi: 10.1111/all.12441.Muraro A, Agache I, Clark A, et al.; European Academy of Allergy and Clinical Immunology. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community. Allergy. 2014;69(8):1046–1057. doi: 10.1111/all.12441.World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013–2020 [Accessed 2019 Febr 25]. Available from: www.who.int.World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013–2020 [Accessed 2019 Febr 25]. Available from: www.who.int.Branca F, Lartey A, Oenema S, et al. Transforming the food system to fight noncommunicable diseases. BMJ. 2019;364:l296. doi: 10.1136/bmj.l296.Branca F, Lartey A, Oenema S, et al. Transforming the food system to fight noncommunicable diseases. BMJ. 2019;364:l296. doi: 10.1136/bmj.l296.Willett W, Rockström J, Loken B, et al. Food in the anthropocene: the EAT-lancet commission on healthy diets from sustainable food systems. Lancet. 2019;393(10170):447-492. doi: 10.1016/S0140-6736(18)31788-4.Willett W, Rockström J, Loken B, et al. Food in the anthropocene: the EAT-lancet commission on healthy diets from sustainable food systems. Lancet. 2019;393(10170):447-492. doi: 10.1016/S0140-6736(18)31788-4.Zimmer J, Vieths S, Kaul S. Standardization and regulation of allergen products in the European Union. Curr Allergy Asthma Rep. 2016;16(3):21. doi: 10.1007/s11882-016-0599-4.Zimmer J, Vieths S, Kaul S. Standardization and regulation of allergen products in the European Union. Curr Allergy Asthma Rep. 2016;16(3):21. doi: 10.1007/s11882-016-0599-4.Bonertz A, Roberts G, Slater JE, et al. Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: an analysis from the EAACI AIT guidelines project. Allergy. 2018;73(4):816–826. doi: 10.1111/all.13357.Bonertz A, Roberts G, Slater JE, et al. Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: an analysis from the EAACI AIT guidelines project. Allergy. 2018;73(4):816–826. doi: 10.1111/all.13357.Bieber T, Vieths S, Broich K. New opportunities and challenges in the assessment of drugs for atopic diseases. Allergy. 2016;71(12):1662–1665. doi: 10.1111/all.13063.Bieber T, Vieths S, Broich K. New opportunities and challenges in the assessment of drugs for atopic diseases. Allergy. 2016;71(12):1662–1665. doi: 10.1111/all.13063.Kaul S, Zimmer J, Dehus O, et al. Standardization of allergen products: 3. Validation of candidate European Pharmacopoeia standard methods for quantification of major birch allergen Bet v 1. Allergy. 2016;71(10):1414–1424. doi: 10.1111/all.12898.Kaul S, Zimmer J, Dehus O, et al. Standardization of allergen products: 3. Validation of candidate European Pharmacopoeia standard methods for quantification of major birch allergen Bet v 1. Allergy. 2016;71(10):1414–1424. doi: 10.1111/all.12898.Zimmer J, Bonertz A, Vieths S. Quality requirements for allergen extracts and allergoids for allergen immunotherapy. Allergol Immunopathol (Madr). 2017;45(Suppl 1):4–11. doi: 10.1016/j.aller.2017.09.002.Zimmer J, Bonertz A, Vieths S. Quality requirements for allergen extracts and allergoids for allergen immunotherapy. Allergol Immunopathol (Madr). 2017;45(Suppl 1):4–11. doi: 10.1016/j.aller.2017.09.002.De Monchy JG, Demoly P, Akdis CA, et al. Allergology in Europe, the blueprint. Allergy 2013;68(10):1211–1218. doi: 10.1111/all.12225.De Monchy JG, Demoly P, Akdis CA, et al. Allergology in Europe, the blueprint. Allergy 2013;68(10):1211–1218. doi: 10.1111/all.12225.Gerth van Wijk R, Eguiluz-Gracia I, Gayraud J, et al. The roadmap for allergology in Europe: The subspecialty of allergology as “stopover” on the way to a full specialty. An EAACI position statement. Allergy. 2018;73(3):540–548. doi: 10.1111/all.13321.Gerth van Wijk R, Eguiluz-Gracia I, Gayraud J, et al. The roadmap for allergology in Europe: The subspecialty of allergology as “stopover” on the way to a full specialty. An EAACI position statement. Allergy. 2018;73(3):540–548. doi: 10.1111/all.13321.Katsaounou P, Odemyr M, Spranger O, et al. Still fighting for breath: a patient survey of the challenges and impact of severe asthma. ERJ Open Res. 2018;4(4):00076–2018. doi: 10.1183/23120541.00076-2018.Katsaounou P, Odemyr M, Spranger O, et al. Still fighting for breath: a patient survey of the challenges and impact of severe asthma. ERJ Open Res. 2018;4(4):00076–2018. doi: 10.1183/23120541.00076-2018.Honkoop PJ, Simpson A, Bonini M, et al. MyAirCoach: the use of home-monitoring and mHealth systems to predict deterioration in asthma control and the occurrence of asthma exacerbations; study protocol of an observational study. BMJ Open. 2017;7:e013935. doi: 10.1136/bmjopen-2016-013935.Honkoop PJ, Simpson A, Bonini M, et al. MyAirCoach: the use of home-monitoring and mHealth systems to predict deterioration in asthma control and the occurrence of asthma exacerbations; study protocol of an observational study. BMJ Open. 2017;7:e013935. doi: 10.1136/bmjopen-2016-013935.Sanyal S, Rochereau T, Maesano C, et al. Long-term effect of outdoor air pollution on mortality and morbidity: a 12-year follow-up study for metropolitan France. Int J Environ Res Public Health. 2018;15(11):2487. doi: 10.3390/ijerph15112487.Sanyal S, Rochereau T, Maesano C, et al. Long-term effect of outdoor air pollution on mortality and morbidity: a 12-year follow-up study for metropolitan France. Int J Environ Res Public Health. 2018;15(11):2487. doi: 10.3390/ijerph15112487.D’Amato G, Annesi-Maesano I, Cecchi L, D’Amato M. Latest news on relationship between thunderstorms and respiratory allergy, severe asthma, and deaths for asthma. Allergy. 2019;74(1):9–11. doi: 10.1111/all.13616.D’Amato G, Annesi-Maesano I, Cecchi L, D’Amato M. Latest news on relationship between thunderstorms and respiratory allergy, severe asthma, and deaths for asthma. Allergy. 2019;74(1):9–11. doi: 10.1111/all.13616.Bousquet J, Anto JM, Akdis M, et al. Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: mechanisms of the development of allergy; EU FP7-CP-IP; project No: 261357; 2010–2015. Allergy. 2016;71(11):1513–1525. doi: 10.1111/all.12880.Bousquet J, Anto JM, Akdis M, et al. Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: mechanisms of the development of allergy; EU FP7-CP-IP; project No: 261357; 2010–2015. Allergy. 2016;71(11):1513–1525. doi: 10.1111/all.12880.Walker SM, Akdis C, Dahlen SE, et al. Building the investment case for asthma R&D: the European asthma research and innovation partnership argument. Clin Exp Allergy. 2016;46(9):1136–1138. doi: 10.1111/cea.12779.Walker SM, Akdis C, Dahlen SE, et al. Building the investment case for asthma R&D: the European asthma research and innovation partnership argument. Clin Exp Allergy. 2016;46(9):1136–1138. doi: 10.1111/cea.12779.Cecchi L, D’Amato G, Annesi-Maesano I. External exposome and allergic respiratory and skin diseases. J Allergy Clin Immunol. 2018;141(3):846–857. doi: 10.1016/j.jaci.2018.01.016.Cecchi L, D’Amato G, Annesi-Maesano I. External exposome and allergic respiratory and skin diseases. J Allergy Clin Immunol. 2018;141(3):846–857. doi: 10.1016/j.jaci.2018.01.016.Agache I, Miller R, Gern JE, et al. Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma. Allergy. 2019;74(3):449–463. doi: 10.1111/all.13690.Agache I, Miller R, Gern JE, et al. Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma. Allergy. 2019;74(3):449–463. doi: 10.1111/all.13690.Migliori GB, Bel E, Joos G, et al. The European Respiratory Society evaluates its 2013–2018 strategic plan implementation. Eur Respir J. 2016;47(3):693–698. doi: 10.1183/13993003.02110-2015.Migliori GB, Bel E, Joos G, et al. The European Respiratory Society evaluates its 2013–2018 strategic plan implementation. Eur Respir J. 2016;47(3):693–698. doi: 10.1183/13993003.02110-2015.Soriano JB, Paton J, Martin Burrieza F, et al. The ERS research agency: the beginning. Eur Respir J. 2016;47(4):1017–1023. doi: 10.1183/13993003.02109-2015.Soriano JB, Paton J, Martin Burrieza F, et al. The ERS research agency: the beginning. Eur Respir J. 2016;47(4):1017–1023. doi: 10.1183/13993003.02109-2015.Maio S, Baldacci S, Bresciani M, et al. RItA: the Italian severe/uncontrolled asthma registry. Allergy. 2018;73(3):683–695. doi: 10.1111/all.13342.Maio S, Baldacci S, Bresciani M, et al. RItA: the Italian severe/uncontrolled asthma registry. Allergy. 2018;73(3):683–695. doi: 10.1111/all.13342.Liu NM, van Aalderen W, Carlsen K, et al. Severe Paediatric Asthma Collaborative in Europe (SPACE): protocol for a European registry. Breathe. 2018;14(2):93–98. doi: 10.1183/20734735.002018.Liu NM, van Aalderen W, Carlsen K, et al. Severe Paediatric Asthma Collaborative in Europe (SPACE): protocol for a European registry. Breathe. 2018;14(2):93–98. doi: 10.1183/20734735.002018.Kercsmar CM, Sorkness CA, Calatroni A, et al. A computerized decision support tool to implement asthma guidelines for children and adolescents. J Allergy Clin Immunol. 2019;143(5):1760–1768. doi: 10.1016/j.jaci.2018.10.060.Kercsmar CM, Sorkness CA, Calatroni A, et al. A computerized decision support tool to implement asthma guidelines for children and adolescents. J Allergy Clin Immunol. 2019;143(5):1760–1768. doi: 10.1016/j.jaci.2018.10.060.Papadopoulos NG, Custovic A, Cabana MD, et al. Pediatric asthma: an unmet need for more effective, focused treatments. Pediatr Allergy Immunol. 2019;30(1):7–16. doi: 10.1111/pai.12990.Papadopoulos NG, Custovic A, Cabana MD, et al. Pediatric asthma: an unmet need for more effective, focused treatments. Pediatr Allergy Immunol. 2019;30(1):7–16. doi: 10.1111/pai.12990.Vishneva E, Namazova-Baranova LV, Alekseeva A, et al. The pediatric asthma patient registry in implementation of long term follow up. Value Health. 2015;18(7):A693.Vishneva E, Namazova-Baranova LV, Alekseeva A, et al. The pediatric asthma patient registry in implementation of long term follow up. Value Health. 2015;18(7):A693.Leiding JW, Ballow M. Precision medicine in the treatment of primary immunodeficiency diseases. Curr Opin Allergy Clin Immunol. 2018;18(2):159–166. doi: 10.1097/ACI.0000000000000431.Leiding JW, Ballow M. Precision medicine in the treatment of primary immunodeficiency diseases. Curr Opin Allergy Clin Immunol. 2018;18(2):159–166. doi: 10.1097/ACI.0000000000000431.Odnoletkova I, Kindle G, Quinti I, et al. Plasma Protein Therapeutics Association (PPTA) Taskforce. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Orphanet J Rare Dis. 2018;13(1):201. doi: 10.1186/s13023-018-0941-0.Odnoletkova I, Kindle G, Quinti I, et al. Plasma Protein Therapeutics Association (PPTA) Taskforce. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Orphanet J Rare Dis. 2018;13(1):201. doi: 10.1186/s13023-018-0941-0.To T, Cruz AA, Viegi G, et al. A strategy for measuring health outcomes and evaluating impacts of interventions on asthma and COPD-common chronic respiratory diseases in Global Alliance against Chronic Respiratory Diseases (GARD) countries. J Thorac Dis. 2018;10(8):5170–5177. doi: 10.21037/jtd.2018.08.100.To T, Cruz AA, Viegi G, et al. A strategy for measuring health outcomes and evaluating impacts of interventions on asthma and COPD-common chronic respiratory diseases in Global Alliance against Chronic Respiratory Diseases (GARD) countries. J Thorac Dis. 2018;10(8):5170–5177. doi: 10.21037/jtd.2018.08.100.Hellings PW, Fokkens WJ, Bachert C, et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis — A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297–1305. doi: 10.1111/all.13162.Hellings PW, Fokkens WJ, Bachert C, et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis — A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297–1305. doi: 10.1111/all.13162.Valiulis A, Bousquet J, Veryga A, et al. Vilnius declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases. Clin Transl Allergy. 2019;9:7. doi: 10.1186/s13601-019-0242-2.Valiulis A, Bousquet J, Veryga A, et al. Vilnius declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases. Clin Transl Allergy. 2019;9:7. doi: 10.1186/s13601-019-0242-2.Butler D. Translational research: crossing the valley of death. Nature. 2008;453:840–842. doi: 10.1038/453840a.Butler D. Translational research: crossing the valley of death. Nature. 2008;453:840–842. doi: 10.1038/453840a.Woolf SH. The meaning of translational research and why it matters. JAMA 2008;299:211–213. doi: 10.1001/jama.2007.26.Woolf SH. The meaning of translational research and why it matters. JAMA 2008;299:211–213. doi: 10.1001/jama.2007.26.Bender BG. A bootstrap approach to implementation science. Ann Allergy Asthma Immunol. 2016;117:213–216. doi: 10.1016/j.anai.2016.07.007.Bender BG. A bootstrap approach to implementation science. Ann Allergy Asthma Immunol. 2016;117:213–216. doi: 10.1016/j.anai.2016.07.007.Cunningham S, Pinnock H. Implementation science takes baby steps in infants with bronchiolitis. Thorax 2018;73(7):599–600. doi: 10.1136/thoraxjnl-2017-211455.Cunningham S, Pinnock H. Implementation science takes baby steps in infants with bronchiolitis. Thorax 2018;73(7):599–600. doi: 10.1136/thoraxjnl-2017-211455.Colborn KL, Helmkamp L, Bender BG, et al. Colorado asthma toolkit implementation improves some process measures of asthma care. J Am Board Fam Med. 2019;32(1):37–49. doi: 10.3122/jabfm.2019.01.180155.Colborn KL, Helmkamp L, Bender BG, et al. Colorado asthma toolkit implementation improves some process measures of asthma care. J Am Board Fam Med. 2019;32(1):37–49. doi: 10.3122/jabfm.2019.01.180155.Crable EL, Biancarelli D, Walkey AJ, et al. Standardizing an approach to the evaluation of implementation science proposals. Implement Sci. 2018;13(1):71. doi: 10.1186/s13012-018-0770-5.Crable EL, Biancarelli D, Walkey AJ, et al. Standardizing an approach to the evaluation of implementation science proposals. Implement Sci. 2018;13(1):71. doi: 10.1186/s13012-018-0770-5.Pinnock H, Barwick M, Carpenter CR, et al. Standards for Reporting Implementation Studies (StaRI) Statement. BMJ. 2017;356:i6795. doi: 10.1136/bmj.i6795.Pinnock H, Barwick M, Carpenter CR, et al. Standards for Reporting Implementation Studies (StaRI) Statement. BMJ. 2017;356:i6795. doi: 10.1136/bmj.i6795.Bonini S, Bonini M. Biosimilars and drug development in immunologic diseases. J Allergy Clin Immunol. 2017;139:1461–1464. doi: 10.1016/j.jaci.2017.03.008.Bonini S, Bonini M. Biosimilars and drug development in immunologic diseases. J Allergy Clin Immunol. 2017;139:1461–1464. doi: 10.1016/j.jaci.2017.03.008.Rasi G, Bonini S. Innovative medicines; new regulatory procedures for the third millennium. Expert Opin Biol Ther. 2015;15:5–8. doi: 10.1517/14712598.2015.1026322.Rasi G, Bonini S. Innovative medicines; new regulatory procedures for the third millennium. Expert Opin Biol Ther. 2015;15:5–8. doi: 10.1517/14712598.2015.1026322.Barnes PJ, Bonini S, Seeger W, et al. Barriers to new drug development in respiratory disease. Eur Respir J. 2015;45(5):1197–1207. doi: 10.1183/09031936.00007915.Barnes PJ, Bonini S, Seeger W, et al. Barriers to new drug development in respiratory disease. Eur Respir J. 2015;45(5):1197–1207. doi: 10.1183/09031936.00007915.Bonini S, Eichler HG, Wathion N, Rasi G. Transparency and the European Medicines Agency. Sharing of clinical trial data. N Engl J Med. 2014;371:2552–2555. doi: 10.1056/NEJMp1409464.Bonini S, Eichler HG, Wathion N, Rasi G. Transparency and the European Medicines Agency. Sharing of clinical trial data. N Engl J Med. 2014;371:2552–2555. doi: 10.1056/NEJMp1409464.Palomares O, Crameri R, Rhyner C. The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases. Allergy. 2014;69(12):1588–1601. doi: 10.1111/all.12533.Palomares O, Crameri R, Rhyner C. The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases. Allergy. 2014;69(12):1588–1601. doi: 10.1111/all.12533.Diver S, Brightling CE. Big asthma data: getting bigger and more beautiful? Thorax. 2018;73(4):311–312. doi: 10.1136/thoraxjnl-2017-211148.Diver S, Brightling CE. Big asthma data: getting bigger and more beautiful? Thorax. 2018;73(4):311–312. doi: 10.1136/thoraxjnl-2017-211148.Pandey G, Pandey OP, Rogers AJ, et al. A nasal brush-based classifier of asthma identified by machine learning analysis of nasal RNA sequence data. Sci Rep. 2018;8(1):8826. doi: 10.1038/s41598-018-27189-4.Pandey G, Pandey OP, Rogers AJ, et al. A nasal brush-based classifier of asthma identified by machine learning analysis of nasal RNA sequence data. Sci Rep. 2018;8(1):8826. doi: 10.1038/s41598-018-27189-4.Ross MK, Yoon J, van der Schaar A, van der Schaar M. Discovering pediatric asthma phenotypes on the basis of response to controller medication using machine learning. Ann Am Thorac Soc. 2018;15(1):49–58. doi: 10.1513/AnnalsATS.201702-101OC.Ross MK, Yoon J, van der Schaar A, van der Schaar M. Discovering pediatric asthma phenotypes on the basis of response to controller medication using machine learning. Ann Am Thorac Soc. 2018;15(1):49–58. doi: 10.1513/AnnalsATS.201702-101OC.Ghosh D, Bernstein JA, Khurana Hershey GK, et al. Leveraging Multilayered “Omics” Data for Atopic Dermatitis: A Road Map to Precision Medicine. Front Immunol. 2018;9:2727. doi: 10.3389/fimmu.2018.02727.Ghosh D, Bernstein JA, Khurana Hershey GK, et al. Leveraging Multilayered “Omics” Data for Atopic Dermatitis: A Road Map to Precision Medicine. Front Immunol. 2018;9:2727. doi: 10.3389/fimmu.2018.02727.Bieber T, Akdis C, Lauener R, et al. Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicine. Allergy. 2016;71(5):588–592. doi: 10.1111/all.12857.Bieber T, Akdis C, Lauener R, et al. Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicine. Allergy. 2016;71(5):588–592. doi: 10.1111/all.12857.Nieuwenhuis MA, Siedlinski M, van den Berge M, et al. Combining genome-wide association study and lung eQTL analysis provides evidence for novel genes associated with asthma. Allergy. 2016;71(12):1712–1720. doi: 10.1111/all.12990.Nieuwenhuis MA, Siedlinski M, van den Berge M, et al. Combining genome-wide association study and lung eQTL analysis provides evidence for novel genes associated with asthma. Allergy. 2016;71(12):1712–1720. doi: 10.1111/all.12990.Loureiro CC, Oliveira AS, Santos M, et al. Urinary metabolomic profiling of asthmatics can be related to clinical characteristics. Allergy. 2016;71(9):1362–1365. doi: 10.1111/all.12935.Loureiro CC, Oliveira AS, Santos M, et al. Urinary metabolomic profiling of asthmatics can be related to clinical characteristics. Allergy. 2016;71(9):1362–1365. doi: 10.1111/all.12935.Obeso D, Mera-Berriatua L, Rodríguez-Coira J, et al. Multiomics analysis points to altered platelet functions in severe foodassociated respiratory allergy. Allergy. 2018;73(11):2137–2149. doi: 10.1111/all.13563.Obeso D, Mera-Berriatua L, Rodríguez-Coira J, et al. Multiomics analysis points to altered platelet functions in severe foodassociated respiratory allergy. Allergy. 2018;73(11):2137–2149. doi: 10.1111/all.13563.Villaseñor A, Rosace D, Obeso D, et al. Allergic asthma: an overview of metabolomic strategies leading to the identification of biomarkers in the field. Clin Exp Allergy. 2017;47(4):442–456. doi: 10.1111/cea.12902.Villaseñor A, Rosace D, Obeso D, et al. Allergic asthma: an overview of metabolomic strategies leading to the identification of biomarkers in the field. Clin Exp Allergy. 2017;47(4):442–456. doi: 10.1111/cea.12902.Rodrigo-Muñoz JM, Cañas JA, Sastre B, et al. Asthma diagnosis using integrated analysis of eosinophil microRNAs. Allergy. 2019;74(3):507–517. doi: 10.1111/all.13570.Rodrigo-Muñoz JM, Cañas JA, Sastre B, et al. Asthma diagnosis using integrated analysis of eosinophil microRNAs. Allergy. 2019;74(3):507–517. doi: 10.1111/all.13570.Doña I, Jurado-Escobar R, Perkins JR, et al. Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti-inflammatory drug-induced urticaria. Allergy. 2019;74(6):1135-1144. doi: 10.1111/all.13725.Doña I, Jurado-Escobar R, Perkins JR, et al. Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti-inflammatory drug-induced urticaria. Allergy. 2019;74(6):1135-1144. doi: 10.1111/all.13725.Segura-Bedmar I, Colon-Ruiz C, Tejedor-Alonso MA, Moro-Moro M. Predicting of anaphylaxis in big data EMR by exploring machine learning approaches. J Biomed Inform. 2018;87:50–59. doi: 10.1016/j.jbi.2018.09.012.Segura-Bedmar I, Colon-Ruiz C, Tejedor-Alonso MA, Moro-Moro M. Predicting of anaphylaxis in big data EMR by exploring machine learning approaches. J Biomed Inform. 2018;87:50–59. doi: 10.1016/j.jbi.2018.09.012.Bousquet J, Agache I, Anto JM, et al. Google Trends terms reporting rhinitis and related topics differ in European countries. Allergy. 2017;72(8):1261–1266. doi: 10.1111/all.13137.Bousquet J, Agache I, Anto JM, et al. Google Trends terms reporting rhinitis and related topics differ in European countries. Allergy. 2017;72(8):1261–1266. doi: 10.1111/all.13137.Bonini M. Electronic health (e-Health): emerging role in asthma. Curr Opin Pulm Med. 2017;23(1):21–26. doi: 10.1097/MCP.0000000000000336.Bonini M. Electronic health (e-Health): emerging role in asthma. Curr Opin Pulm Med. 2017;23(1):21–26. doi: 10.1097/MCP.0000000000000336.Eguiluz-Gracia I, Tay TR, Hew M, et al. Recent developments and highlights in biomarkers in allergic diseases and asthma. Allergy. 2018;73(12):2290–3230. doi: 10.1111/all.13628.Eguiluz-Gracia I, Tay TR, Hew M, et al. Recent developments and highlights in biomarkers in allergic diseases and asthma. Allergy. 2018;73(12):2290–3230. doi: 10.1111/all.13628.Agache I, Rogozea L. Endotypes in allergic diseases. Curr Opin Allergy Clin Immunol. 2018;18(3):177–183. doi: 10.1097/ACI.0000000000000434.Agache I, Rogozea L. Endotypes in allergic diseases. Curr Opin Allergy Clin Immunol. 2018;18(3):177–183. doi: 10.1097/ACI.0000000000000434.Agache I, Strasser DS, Pierlot GM, et al. Monitoring inflammatory heterogeneity with multiple biomarkers for multidimensional endotyping of asthma. J Allergy Clin Immunol. 2018;141(1):442–445. doi: 10.1016/j.jaci.2017.08.027.Agache I, Strasser DS, Pierlot GM, et al. Monitoring inflammatory heterogeneity with multiple biomarkers for multidimensional endotyping of asthma. J Allergy Clin Immunol. 2018;141(1):442–445. doi: 10.1016/j.jaci.2017.08.027.Muraro A, Lemanske RF, Hellings PW, et al. Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy Asthma & Immunology. J Allergy Clin Immunol. 2016;137(5):1347–1358. doi: 10.1016/j.jaci.2016.03.010.Muraro A, Lemanske RF, Hellings PW, et al. Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy Asthma & Immunology. J Allergy Clin Immunol. 2016;137(5):1347–1358. doi: 10.1016/j.jaci.2016.03.010.Finkelstein J, Wood J. Predicting asthma exacerbations using artificial intelligence. Stud Health Technol Inform. 2013;190:56–58.Finkelstein J, Wood J. Predicting asthma exacerbations using artificial intelligence. Stud Health Technol Inform. 2013;190:56–58.Finkelstein J, Jeong IC. Machine learning approaches to personalize early prediction of asthma exacerbations. Ann N Y Acad Sci. 2017;1387(1):153–165. doi: 10.1111/nyas.13218.Finkelstein J, Jeong IC. Machine learning approaches to personalize early prediction of asthma exacerbations. Ann N Y Acad Sci. 2017;1387(1):153–165. doi: 10.1111/nyas.13218.Sukumar SR, Natarajan R, Ferrell RK. Quality of big data in health care. Int J Health Care Qual Assur. 2015;28(6):621–634. doi: 10.1108/IJHCQA-07-2014-0080.Sukumar SR, Natarajan R, Ferrell RK. Quality of big data in health care. Int J Health Care Qual Assur. 2015;28(6):621–634. doi: 10.1108/IJHCQA-07-2014-0080.Hordern V. Data protection compliance in the age of digital health. Eur J Health Law. 2016;23(3):248–264. doi: 10.1163/15718093-12341393.Hordern V. Data protection compliance in the age of digital health. Eur J Health Law. 2016;23(3):248–264. doi: 10.1163/15718093-12341393.Rumbold JM, Pierscionek B. The effect of the general data protection regulation on medical research. J Med Internet Res. 2017;19(2):e47. doi: 10.2196/jmir.7108.Rumbold JM, Pierscionek B. The effect of the general data protection regulation on medical research. J Med Internet Res. 2017;19(2):e47. doi: 10.2196/jmir.7108.Garcia-Larsen V, Del Giacco SR, Moreira A, et al. Asthma and dietary intake: an overview of systematic reviews. Allergy 2016;71(4):433–442. doi: 10.1111/all.12800.Garcia-Larsen V, Del Giacco SR, Moreira A, et al. Asthma and dietary intake: an overview of systematic reviews. Allergy 2016;71(4):433–442. doi: 10.1111/all.12800.Paciência I, Cavaleiro Rufo J, Silva D, et al. Exposure to indoor endocrine disrupting chemicals and childhood asthma and obesity. Allergy. 2019;74(7):1277-1291. doi: 10.1111/all.13740.Paciência I, Cavaleiro Rufo J, Silva D, et al. Exposure to indoor endocrine disrupting chemicals and childhood asthma and obesity. Allergy. 2019;74(7):1277-1291. doi: 10.1111/all.13740.Steckling N, Gotti A, Bose-O’Reilly S, et al. Biomarkers of exposure in environment-wide association studies Opportunities to decode the exposome using human biomonitoring data. Environ Res. 2018;164:597–624. doi: 10.1016/j.envres.2018.02.041.Steckling N, Gotti A, Bose-O’Reilly S, et al. Biomarkers of exposure in environment-wide association studies Opportunities to decode the exposome using human biomonitoring data. Environ Res. 2018;164:597–624. doi: 10.1016/j.envres.2018.02.041.Krautenbacher N, Flach N, Böck A, et al. A strategy for high-dimensional multivariable analysis classifies childhood asthma phenotypes from genetic, immunological and environmental factors. Allergy. 2019;74(7):1364-1373. doi: 10.1111/all.13745.Krautenbacher N, Flach N, Böck A, et al. A strategy for high-dimensional multivariable analysis classifies childhood asthma phenotypes from genetic, immunological and environmental factors. Allergy. 2019;74(7):1364-1373. doi: 10.1111/all.13745.Venter C, Meyer RW, Nwaru BI, et al. EAACI position paper: influence of dietary fatty acids on asthma, food allergy and atopic dermatitis. Allergy. 2019;74(8):1429-1444. doi: 10.1111/all.13764.Venter C, Meyer RW, Nwaru BI, et al. EAACI position paper: influence of dietary fatty acids on asthma, food allergy and atopic dermatitis. Allergy. 2019;74(8):1429-1444. doi: 10.1111/all.13764.Wickens K, Barthow C, Mitchell EA, et al. Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years. Pediatr Allergy Immunol. 2018;29(8):808–814. doi: 10.1111/pai.12982.Wickens K, Barthow C, Mitchell EA, et al. Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years. Pediatr Allergy Immunol. 2018;29(8):808–814. doi: 10.1111/pai.12982.Lerner H, Berg C. The concept of health in One Health and some practical implications for research and education: what is One Health? Infect Ecol Epidemiol. 2015;5:25300. doi: 10.3402/iee.v5.25300.Lerner H, Berg C. The concept of health in One Health and some practical implications for research and education: what is One Health? Infect Ecol Epidemiol. 2015;5:25300. doi: 10.3402/iee.v5.25300.Xie T, Liu W, Anderson BD, et al. A system dynamics approach to understanding the One Health concept. PLoS ONE. 2017;12(9):e0184430. doi: 10.1371/journal.pone.0184430.Xie T, Liu W, Anderson BD, et al. A system dynamics approach to understanding the One Health concept. PLoS ONE. 2017;12(9):e0184430. doi: 10.1371/journal.pone.0184430.Khan SJ, Dharmage SC, Matheson MC, Gurrin LC. Is the atopic march related to confounding by genetics and early-life environment? A systematic review of sibship and twin data. Allergy. 2018;73(1):17–28. doi: 10.1111/all.13228.Khan SJ, Dharmage SC, Matheson MC, Gurrin LC. Is the atopic march related to confounding by genetics and early-life environment? A systematic review of sibship and twin data. Allergy. 2018;73(1):17–28. doi: 10.1111/all.13228.Lockett GA, Soto-Ramírez N, Ray MA, et al. Association of sea son of birth with DNA methylation and allergic disease. Allergy. 2016;71(9):1314–1324. doi: 10.1111/all.12882.Lockett GA, Soto-Ramírez N, Ray MA, et al. Association of sea son of birth with DNA methylation and allergic disease. Allergy. 2016;71(9):1314–1324. doi: 10.1111/all.12882.Savage JH, Lee-Sarwar KA, Sordillo J, et al. A prospective microbiome-wide association study of food sensitization and food allergy in early childhood. Allergy. 2018;73(1):145–152. doi: 10.1111/all.13232.Savage JH, Lee-Sarwar KA, Sordillo J, et al. A prospective microbiome-wide association study of food sensitization and food allergy in early childhood. Allergy. 2018;73(1):145–152. doi: 10.1111/all.13232.Jatzlauk G, Bartel S, Heine H, et al. Influences of environmental bacteria and their metabolites on allergies, asthma, and host microbiota. Allergy. 2017;72(12):1859–1867. doi: 10.1111/all.13220.Jatzlauk G, Bartel S, Heine H, et al. Influences of environmental bacteria and their metabolites on allergies, asthma, and host microbiota. Allergy. 2017;72(12):1859–1867. doi: 10.1111/all.13220.Birzele LT, Depner M, Ege MJ, et al. Environmental and mucosal microbiota and their role in childhood asthma. Allergy. 2017;72(1):109–119. doi: 10.1111/all.13002.Birzele LT, Depner M, Ege MJ, et al. Environmental and mucosal microbiota and their role in childhood asthma. Allergy. 2017;72(1):109–119. doi: 10.1111/all.13002.Muir AB, Benitez AJ, Dods K, et al. Microbiome and its impact on gastrointestinal atopy. Allergy. 2016;71(9):1256–1263. doi: 10.1111/all.12943.Muir AB, Benitez AJ, Dods K, et al. Microbiome and its impact on gastrointestinal atopy. Allergy. 2016;71(9):1256–1263. doi: 10.1111/all.12943.Lau S, Matricardi PM, Wahn U, et al. Allergy and atopy from infancy to adulthood: messages from the German birth cohort MAS. Ann Allergy Asthma Immunol. 2019;122(1):25–32. doi: 10.1016/j.anai.2018.05.012.Lau S, Matricardi PM, Wahn U, et al. Allergy and atopy from infancy to adulthood: messages from the German birth cohort MAS. Ann Allergy Asthma Immunol. 2019;122(1):25–32. doi: 10.1016/j.anai.2018.05.012.Thacher JD, Gruzieva O, Pershagen G, et al. Parental smoking and development of allergic sensitization from birth to adolescence. Allergy. 2016;71(2):239–248. doi: 10.1111/all.12792.Thacher JD, Gruzieva O, Pershagen G, et al. Parental smoking and development of allergic sensitization from birth to adolescence. Allergy. 2016;71(2):239–248. doi: 10.1111/all.12792.Fuertes E, Markevych I, Bowatte G, et al. Residential greenness is differentially associated with childhood allergic rhinitis and aeroallergen sensitization in seven birth cohorts. Allergy. 2016;71(10):1461–1471. doi: 10.1111/all.12915.Fuertes E, Markevych I, Bowatte G, et al. Residential greenness is differentially associated with childhood allergic rhinitis and aeroallergen sensitization in seven birth cohorts. Allergy. 2016;71(10):1461–1471. doi: 10.1111/all.12915.Schröder PC, Illi S, Casaca VI, et al. A switch in regulatory T cells through farm exposure during immune maturation in childhood. Allergy. 2017;72(4):604–615. doi: 10.1111/all.13069.Schröder PC, Illi S, Casaca VI, et al. A switch in regulatory T cells through farm exposure during immune maturation in childhood. Allergy. 2017;72(4):604–615. doi: 10.1111/all.13069.Benet M, Albang R, Pinart M, et al. Integrating clinical and epidemiologic data on allergic diseases across birth cohorts: a harmonization study in the mechanisms of the development of allergy project. Am J Epidemiol. 2019;188(2):408–417. doi: 10.1093/aje/kwy242.Benet M, Albang R, Pinart M, et al. Integrating clinical and epidemiologic data on allergic diseases across birth cohorts: a harmonization study in the mechanisms of the development of allergy project. Am J Epidemiol. 2019;188(2):408–417. doi: 10.1093/aje/kwy242.Hellings PW, Fokkens WJ, Bachert C, et al. ARIA and EPOS working groups positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis — A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297–1305. doi: 10.1111/all.13162.Hellings PW, Fokkens WJ, Bachert C, et al. ARIA and EPOS working groups positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis — A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297–1305. doi: 10.1111/all.13162.

The authors declare that there are no conflicts of interest present.